Retrospective Study
Copyright ©The Author(s) 2024.
World J Virol. Dec 25, 2024; 13(4): 95986
Published online Dec 25, 2024. doi: 10.5501/wjv.v13.i4.95986
Table 3 Reverse transcription-polymerase chain reaction positive detection rates in cerebrospinal fluid and urine samples, n (%)
Days after
symptoms onset
WNV RT-PCR CSF
WNV RT-PCR Urine
Tested
Positive
Tested
Positive
≤ 7 22 (35.5)8 (36.4)17 (30.9)5 (29.4)
8–14 32 (51.6)10 (31.2)30 (54.6)20 (66.6)
≥ 15 8 (12.9)2 (25.0)8 (14.5)5 (62.5)
Total62 (100)20 (32.2)55 (100)30 (54.4)